Y-mAbs Therapeutics Inc.

05/30/2017 | Press release | Archived content

ASCO 2017: A Curative Approach to Central Nervous System Metastases of Neuroblastoma (db757a)

Y-mAbs Therapeutics Inc. published this content on May 30, 2017, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 11, 2025 at 18:52 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io